ID | 113590 |
タイトル別表記 | IFITM1 promotes the invasion at the early stage of head and neck cancer progression
IFITM1 Promotes Invasion of HNSCC Cells
|
著者 |
Hatano, Hiroko
Hiroshima University
Ogawa, Ikuko
Hiroshima University
Kikuchi, Akira
Hiroshima University
Abiko, Yoshimitsu
Nihon University
高田, 隆
Hiroshima University
|
キーワード | IFITM1
invasion
head and neck cancer
|
資料タイプ |
学術雑誌論文
|
抄録 | Purpose: Head and neck squamous cell carcinoma (HNSCC), one of the most common types of human cancer, show persistent invasion that frequently leads to local recurrence and distant lymphatic metastasis. However, molecular mechanisms associated with invasion of HNSCC remain poorly understood. We identified Interferon-induced transmembrane protein 1 (IFITM1) as a candidate gene for promoting the invasion of HNSCC by comparing the gene expression profiles between parent and a highly invasive clone. Therefore, we examined the role of IFITM1 in the invasion of HNSCC.
Experimental Design: IFITM1 expression was examined in HNSCC cell lines and cases by RT-PCR and immunohistochemistry. IFITM1 overexpressing and knockdown cells were generated, and the invasiveness of these cells was examined by in vitro invasion assay. Gene expression profiling of HNSCC cells overexpressing IFITM1 versus control cells was examined by microarray. Results: HNSCC cells expressed IFITM1 mRNA at higher levels, while normal cells did not express. By immunohistochemistry, IFITM1 expression was observed in early invasive HNSCC and invasive HNSCC. Interestingly, IFITM1 was expressed at the invasive front of early invasive HNSCC, and higher expression of IFITM1 was found in invasive HNSCC. In fact, IFITM1 overexpression promoted and IFITM1 knockdown suppressed the invasion of HNSCC cells in vitro. Gene expression profiling of HNSCC cells overexpressing IFITM1 versus control cells revealed that several genes including matrix metalloproteinase were up-regulated in IFITM1 overexpressing cells. Conclusion: Our findings suggest that IFITM1 plays an important role for the invasion at the early stage of HNSCC progression, and that IFITM1 can be a therapeutic target for HNSCC. |
掲載誌名 |
Clinical Cancer Research
|
ISSN | 10780432
15573265
|
cat書誌ID | AA11029881
AA12004900
|
出版者 | The American Association for Cancer Research
|
巻 | 14
|
号 | 19
|
開始ページ | 6097
|
終了ページ | 6105
|
発行日 | 2008-09-30
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
著者版
|
部局 |
歯学系
医学系
|